23073628 |
Stem cell factor receptor/c-Kit: from basic science to clinical implications
Rönnstrand, L,
Lennartsson, J
|
Physiol. Rev. |
2012 |
14695343 |
KIT mutations are common in testicular seminomas
McGreevey, L,
Corless, CL,
Fletcher, JA,
Kemmer, K,
Heinrich, MC,
Cummings, OW,
Town, A,
Haley, A,
Griffith, D,
Wait, C
|
Am. J. Pathol. |
2004 |
22089421 |
Gastrointestinal stromal tumours: origin and molecular oncology
Barnett, CM,
Corless, CL,
Heinrich, MC
|
Nat. Rev. Cancer |
2011 |
16707477 |
Therapeutic effect of imatinib in gastrointestinal stromal tumors: AKT signaling dependent and independent mechanisms
Eisenberg, B,
Tarn, C,
Godwin, AK,
Skorobogatko, YV,
von Mehren, M,
Taguchi, T
|
Cancer Res. |
2006 |
28192400 |
Oncogenic signaling by Kit tyrosine kinase occurs selectively on the Golgi apparatus in gastrointestinal stromal tumors
Akieda, Y,
Abe, R,
Obata, Y,
Nishida, T,
Esumi, H,
Fletcher, JA,
Takahashi, T,
Tsujimoto, M,
Horikawa, K
|
Oncogene |
2017 |
28403213 |
M-COPA suppresses endolysosomal Kit-Akt oncogenic signalling through inhibiting the secretory pathway in neoplastic mast cells
Shiina, I,
Murata, T,
Abe, R,
Tasaki, Y,
Obata, Y,
Hara, Y,
Suzuki, K,
Horikawa, K
|
PLoS ONE |
2017 |
16188233 |
KIT (c-kit oncogene product) pathway is constitutively activated in human testicular germ cell tumors
Nakai, Y,
Miki, T,
Inoue, H,
Oka, D,
Mizutani, Y,
Nakayama, M,
Okuyama, A,
Nonomura, N,
Shiba, M,
Arai, Y,
Nishimura, K,
Aozasa, K
|
Biochem. Biophys. Res. Commun. |
2005 |
16908864 |
Oncogenic Kit signaling and therapeutic intervention in a mouse model of gastrointestinal stromal tumor
Antonescu, CR,
Viale, A,
Ehlers, I,
Yozgat, Y,
Besmer, P,
Socci, ND,
Manova, K,
Sommer, G,
Agosti, V,
Rossi, F
|
Proc. Natl. Acad. Sci. U.S.A. |
2006 |
17452978 |
KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance
Fletcher, CD,
Ou, WB,
Cohen, PS,
Zhu, MJ,
Demetri, GD,
Fletcher, JA
|
Oncogene |
2007 |
28923937 |
Direct engagement of the PI3K pathway by mutant KIT dominates oncogenic signaling in gastrointestinal stromal tumor
Antonescu, CR,
Veach, D,
Ehlers, I,
Yozgat, Y,
Warpinski, K,
Besmer, P,
Zhang, JQ,
Kwok, A,
Bosbach, B,
Loo, J,
Berrozpe, G,
Rossi, F,
Manova, K,
DeMatteo, RP
|
Proc. Natl. Acad. Sci. U.S.A. |
2017 |
17546049 |
KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway
Demetri, GD,
Bauer, S,
Fletcher, JA,
Duensing, A
|
Oncogene |
2007 |